What about compliance?

European Journal of Contraception and Reproductive Health Care

Volumn 15, Issue 4, 2010, Pages 217-219

  Lasa, Iñaki Lete ^a  

^a NONE

Author keywords

Abortion; Compliance; Condom use; Contraceptive failure; Oral contraceptives

Indexed keywords

LOW DOSE ORAL CONTRACEPTIVE; MESTRANOL PLUS NORETYNODREL;

ABORTION; CONDOM; CONTRACEPTION; EDITORIAL; FERTILE PERIOD; INTRAUTERINE CONTRACEPTIVE DEVICE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; TREATMENT FAILURE;

ABORTION, INDUCED; CONTRACEPTION; CONTRACEPTION BEHAVIOR; CONTRACEPTIVES, ORAL; HUMANS; PATIENT COMPLIANCE;

EID: 77956315269     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2010.503600     Document Type: Editorial

References (12)

1. Skouby SO. Contraceptive use and behavior in the 21st century: A comprehensive study. Eur J Contracept Reprod Health Care 2004;9:57-68.
2. Hillard PJA. Oral contraception non-compliance. The extent of the problem. Adv Contracept 1992;8:S13-S20.
3. Grimes DA. Forgettable contraception. Contraception 2009;80:497-499
4. www. Equipodaphne.es. Accessed 31 May 2010.
5. Potter L, Oakley D, de Leon-Wong E, Canãamar R. Measuring compliance among oral contraceptive users. Fam Plann Perspect 1996;28:154-158
6. Rosemberg M, Waugh MS, Burnhill M. Compliance, counseling and satisfaction with oral contraceptives. A prospective evaluation. Fam Plann Perspect 1998;30:89-104.
7. Moreau C, Cleland K, Trussell J. Contraceptive discontinuation attributed to method dissatisfaction in the United States. Contraception 2007;76:267-272
8. Lete I, Lertxundi R, Landa MC, et al. Observational study of compliance, tolerability, acceptability and cycle control of two oral contraceptives. Rev Iber Fertil 2002;19:427-431
9. Lopez LM, Grimes DA, Gallo MF, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev 2010, Issue 3 Art. No: CD003552. DOI: 10.1002/14651858.
10. Lete I, Doval JL, Pérez-Campos E, et al. Self-described impact of noncompliance among users of a combined hormonal contraceptive method. Contraception 2008;77: 276-282
11. Emkey R, Koltun W, Beusterien K, et al. Patient preference for a once-monthly ibandronate versus once-weekly alendronate in a randomized openlabel cross-over trial: the Bonviva Alendronate Trial in Osteoporosis (BALTO). Curr Med Res Opin 2005;21: 1895-1903
12. Lete I, Doval JL, Pérez-Campos E, et al. Factors affecting women's selection of a combined hormonal contraceptive method: the TEAM-06 Spanish cross-sectional study. Contraception 2007;76:77-83.